Cargando…

Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients”

Detalles Bibliográficos
Autores principales:	Marcus-Mandelblit, Nufar, Ashkenazi-Hoffnung, Liat, Scheuerman, Oded
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc on behalf of American Academy of Allergy, Asthma & Immunology 2023
Materias:	Correspondence and Replies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989502/ https://www.ncbi.nlm.nih.gov/pubmed/36894285 http://dx.doi.org/10.1016/j.jaip.2022.11.049

Ejemplares similares

SARS-CoV-2 symptomatic reinfection among patients with primary antibody deficiency
por: Marcus, Nufar, et al.
Publicado: (2022)

SARS-CoV-2 reinfection or persistence among immunodeficient patients
por: Özdemir, Öner
Publicado: (2023)

Author’s reply to comment on: A higher frequency of physical activity is associated with reduced rates of SARS-CoV-2 infection
por: Green, Ilan, et al.
Publicado: (2023)

The impact of inhaled corticosteroid on SARS-CoV2 infection
por: Lai, Chih-Cheng
Publicado: (2021)

Reply to Schulte-Pelkum, J. Comment on “Favresse et al. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. Microorganisms 2021, 9, 556”
por: Favresse, Julien, et al.
Publicado: (2021)

Reply to: Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations exclude differentials
por: Kania, Karolina, et al.
Publicado: (2021)

A case of SARS-CoV-2 reinfection in Ecuador
por: Prado-Vivar, Belén, et al.
Publicado: (2021)

Reply to Taylor et al. Comment on “Manna et al. SARS-CoV-2 Inactivation in Aerosol by Means of Radiated Microwaves. Viruses 2023, 15, 1443”
por: Manna, Antonio, et al.
Publicado: (2023)

Reply to McDonald, “Protections against the Risk of Airborne SARS-CoV-2 Infection”
por: Dietz, Leslie, et al.
Publicado: (2020)

Severe sinus bradycardia associated with remdesivir in a child with severe SARS-COV-2 infection—reply
por: Mendez-Echevarria, Ana, et al.
Publicado: (2021)

Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Viable virus shedding during SARS-CoV-2 reinfection
por: Letizia, Andrew G, et al.
Publicado: (2021)

Reply to Kulić, Ž. Comment on “Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2. Viruses 2023, 15, 1299”
por: Subhadra, Bobban, et al.
Publicado: (2023)

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

Reply to D. O'Reilly et al
por: Patel, Amol, et al.
Publicado: (2021)

Reinfection with SARS-CoV-2: A case report from Libya
por: Teka, Ibrahim A., et al.
Publicado: (2021)

Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection
por: Pallett, Scott JC., et al.
Publicado: (2021)

Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Reply to “PEG skin testing for COVID-19 allergy”
por: Banerji, Aleena, et al.
Publicado: (2021)

Reply to “Mortality-related immune features and COVID-19”
por: Cai, Li, et al.
Publicado: (2021)

Reply to Ialongo et al. Vitamin D, SARS-CoV-2 and Causal Associations in Transversal Studies: The Time-Series Analysis to Reveal Potential Confounders. Comment on “Gaudio et al. Vitamin D Levels Are Reduced at the Time of Hospital Admission in Sicilian SARS-CoV-2-Positive Patients. Int. J. Environ. Res. Public Health 2021, 18, 3491”
por: Gaudio, Agostino, et al.
Publicado: (2021)

Reply
por: Villa, E, et al.
Publicado: (2001)

In reply:
por: Starčević Čizmarević, Nada, et al.
Publicado: (2021)

Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
por: Pallett, Scott J C, et al.
Publicado: (2021)

Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
por: Chemaitelly, Hiam, et al.
Publicado: (2021)

SARS-CoV-2 Infection Among Health Care Workers Despite the Use of Surgical Masks and Physical Distancing—the Role of Airborne Transmission
por: Goldberg, Lotem, et al.
Publicado: (2021)

Reply to Letter to the Editor: “How Does SARS-CoV-2 Fragment the QRS?”
por: Halil Özdemir, İbrahim, et al.
Publicado: (2022)

Reply to Zandi, M.; Soltani, S. Comment on “Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. Pharmaceutics 2021, 13, 502”
por: Alfassam, Haya A., et al.
Publicado: (2022)

Reply to “Does asthma affect outcomes of patients with COVID-19 infections?”
por: Mahdavinia, Mahboobeh, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection – Authors' reply
por: von Weyhern, Claus Hann, et al.
Publicado: (2021)

The Authors’ Reply
por: Mallik, Sarmila, et al.
Publicado: (2012)

The authors’ reply
por: El-Kannishy, Ghada M.
Publicado: (2018)

The authors’ reply
por: Kim, Hyo Shik, et al.
Publicado: (2017)

Authors’ reply
por: Myrtennäs, Kerstin, et al.
Publicado: (2017)

The author’s reply
por: Park, Chun Soo
Publicado: (2022)

The author’s reply
por: Park, Hyung Joo
Publicado: (2022)

Reply to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”
por: Bansal, Priya, et al.
Publicado: (2021)

Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium”
por: Ballow, Mark, et al.
Publicado: (2021)

Persistent Viral Shedding after SARS-CoV-2 Infection in an Infant with Severe Combined Immunodeficiency
por: Hariharan, Sankar Vaikom, et al.
Publicado: (2021)

Reply to the Letter “Create Guidelines for Characterization of Venom Peptides” from Dr. Volker Herzig
por: Gomez, Marcus Vinicius
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lthu057rc41ge4viock48fka5u